The Efficacy, Safety And Toleration Of CP-866,087 In Pre-Menopausal Women With Female Sexual Arousal Disorder.

• Status: Completed
• Trial end date: 2008-10-01

Summary

CP-866,087 is a non-hormonal compound, acting on the central nervous system, which has been shown in animal models to restore sexual function.

• Phase: Phase 2

Details

• Lead Sponsor: Pfizer